Skip to content
Toggle main navigation
Cure HHT logo
Cure HHT logo
  • Cure HHT Research Network
  • About
  • Resources
    • Scientific Conference
    • CME
    • International HHT Guidelines
    • CHORUS
    • Research Roadmap
  • CureHHT.org
    Log in
    Request to join
    Contact
    Cure HHT
    ResearchNetwork@curehht.org
    Community engagement platform by Hivebrite.

    News and Announcements

    The latest news and announcements from Cure HHT related to the medical and scientific community.

    Submit Your News Here!
    Filter by category
    All
    Basic Science
    Brag board
    Case Report
    Cure HHT News
    Editorial
    Events and Conferences
    Funding announcements
    International
    Primary Manuscript
    Publication alerts
    See all

    Results (5)

    PATH Trial for HHT Published in NEJM!

    PATH Trial for HHT Published in NEJM!

    The NIH-Sponsored PATH Trial Becomes First Positive Randomized Clinical Trial for HHT A huge congratulations to the investigators of this trial, the site PIs, coordinators, and importantly, the patients. NIH Press ReleasePublication Link (also attached)NEJM Quick Take Video
    September 20, 2024
    Consensus Guidelines for Variant Interpretation in ENG and ACVRL1

    Consensus Guidelines for Variant Interpretation in ENG and ACVRL1

    A group of HHT researchers was assembled to serve on a 'Variant Curation Expert Panel (VCEP)' to develop criteria for evaluating the pathogenicity of variants in ENG and ACVRL1 and to review variants in the ClinGen database. Their recent publication details the modifications made to variant interpretation guidelines of the American College of Medical Genetics and Genomics (ACMG) and the Associatio
    May 30, 2024
    Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors

    Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors

    AbstractHeterozygous activin receptor-like kinase 1 (ALK1) mutations are associated with two vascular diseases: hereditary hemorrhagic telangiectasia (HHT) and more rarely pulmonary arterial hypertension (PAH). Here, we aimed to understand the impact of ALK1 mutations on BMP9 and BMP10 transcriptomic responses in endothelial cells. Endothelial colony-forming cells (ECFCs) and microvascular endothe
    February 6, 2024
    Manuscript Summary - ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia

    Manuscript Summary - ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic Telangiectasia

    ANG2 Blockade Diminishes Proangiogenic Cerebrovascular Defects Associated With Models of Hereditary Hemorrhagic TelangiectasiaPublished on June 8, 2023A new study from the lab of Dr. Stryder Meadows at Tulane University – Summarized by Adella Guidroz and Shreya Bavishi The General Question: Is elevated angiopoietin 2 (ANG2) in the endothelium a conserved feature in mouse models of HHT that can be
    January 30, 2024
    Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT

    Comparing Characteristics and Treatment of Brain Vascular Malformations in Children and Adults with HHT

    A new study from the Brain Vascular Malformation Consortium (BVMC) HHT Investigator Group - Summarized by Cassi FridayThe General Question: Are kids the same as adults in terms of brain vascular malformations related to HHT? The Problem: Before this study, there was not a lot of information published looking at brain vascular malformations in children, the symptoms these malformations cause, their
    December 9, 2023